4
Changes in Ownership
Theriva Biologics, Inc. Filed Acc 0001104659-23-010108
CEO and CFO bought 25,000 shares at $0.94 ($23,513)
From the SEC's structured data for this filing
Trades in this filing
SHALLCROSS STEVEN A · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-02 | Purchase : show line 1 in the form | +25,000 | $0.94 | $23,513 | 185,000 | D |
| Open-market purchases · 25,000 sh · avg $0.94 · $23,513 | ||||||
Loading xslF345X03/tm235343-1_4seq1.xml…